Low Dose Naltrexone in the Treatment of HIV Infection (Abstract)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

Low Dose Naltrexone in the Treatment of HIV Infection
      by Bernard Bihari, MD

Low Dose Naltrexone (LDN)
September 1996
https://www.lowdosenaltrexone.org/ldn_hiv_1996.htm

Brief summary of the history of the development of low dose naltrexone as an immune-enhancing agent in the treatment of HIV/AIDS

Keywords: low dose naltrexone, HIV, AIDs, placebo-controlled trial, endorphins, immune system, beta endorphin, metenkephalin, opportunistic infections

Keywords by  Erin Williams, student, St. Louis College of Pharmacy